Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis

被引:0
作者
Deepak Kumar Singh
Puja Sakhuja
Veena Malhotra
Ranjana Gondal
Shiv Kumar Sarin
机构
[1] Govind Ballabh Pant Hospital,Department of Pathology
[2] Govind Ballabh Pant Hospital,Department of Gastroenterology
来源
Digestive Diseases and Sciences | 2008年 / 53卷
关键词
Asian-Indian; Liver; NASH; Non-alcoholic steatohepatitis; Predictors;
D O I
暂无
中图分类号
学科分类号
摘要
Aim To identify the clinical and biochemical predictors of histologic disease severity in patients with non-alcoholic steatohepatitis (NASH). Method Clinical, anthropometric and biochemical data of 71 consecutive patients with a histological diagnosis of NASH were retrieved from the medical database. The histologic criteria proposed at the American Association for the Study of Liver Diseases Conference (2003) were followed. Histologic features and the necro-inflammatory grade of liver biopsy were scored in accordance with the Brunt score. Statistical analysis was performed to identify predictors of disease severity. Results The male to female ratio of the study cohort was 3.1:1. The mean body mass index (BMI) of the patients was 25.67 ± 1.9 kg/m2. In terms of necroinflammatory grading, 21 (29.6%) patients were classified as grade 1, 26 (36.6%) as grade 2 and 24 (33.8%) as grade 3. Multivariate analysis revealed that BMI (P = 0.009), waist circumference (P = 0.035), waist:hip ratio (P = 0.011) and aspartate aminotransferase levels (P < 0.001) were independent predictors of necroinflammatory grade and that female gender (P = 0.02), serum alkaline phosphatase levels (P = 0.018), cholesterol levels (P = 0.048) and low-density lipoprotein (LDL) levels (P = 0.025) were independent predictors of fibrosis stage. Conclusion Female gender, BMI, waist:hip ratio, hypercholesterolemia and LDL levels are independent predictors of disease severity in patients with NASH and may influence the decision to biopsy.
引用
收藏
页码:1967 / 1976
页数:9
相关论文
共 50 条
  • [31] Sophocarpine alleviates non-alcoholic steatohepatitis in rats
    Song, Chun-Yan
    Zeng, Xin
    Chen, Si-Wen
    Hu, Ping-Fang
    Zheng, Zhi-Wu
    Ning, Bei-Fang
    Shi, Jian
    Xie, Wei-Fen
    Chen, Yue-Xiang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (04) : 765 - 774
  • [32] Non-alcoholic steatohepatitis: Clinical significance and pathogenesis
    de Knegt, RJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 : 88 - 92
  • [33] Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis
    Sanchez-Jimenez, Beatriz A.
    Brizuela-Alcantara, Diana
    Ramos-Ostos, Martha H.
    Alva-Lopez, Luis F.
    Uribe-Esquivel, Misael
    Chavez-Tapia, Norberto C.
    ALCOHOL, 2018, 69 : 63 - 67
  • [34] Effect of resveratrol on experimental non-alcoholic steatohepatitis
    Heeboll, Sara
    Thomsen, Karen Louise
    Clouston, Andrew
    Sundelin, Elias Immanuel
    Radko, Yulia
    Christensen, Lars Porskjaer
    Ramezani-Moghadam, Mehdi
    Kreutzfeldt, Martin
    Pedersen, Steen Bonlokke
    Jessen, Niels
    Hebbard, Lionel
    George, Jacob
    Gronbaek, Henning
    PHARMACOLOGICAL RESEARCH, 2015, 95-96 : 34 - 41
  • [35] Investigation of genome instability in patients with non-alcoholic steatohepatitis
    Karaman, Hatice
    Karaman, Ahmet
    Donmez-Altuntas, Hamiyet
    Bitgen, Nazmiye
    Hamurcu, Zuhal
    Oguz, Arzu
    Karakukcu, Cigdem
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (32) : 5295 - 5301
  • [36] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [37] Modification of dietary patterns in patients with non-alcoholic steatohepatitis
    Sasunova, Armida N.
    Goncharov, Alexey A.
    Morozov, Sergey V.
    Isakov, Vasily A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (08) : 973 - 978
  • [38] Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis
    Nakamura, Shinichi
    Konishi, Hiroyuki
    Kishino, Maiko
    Yatsuji, Satoru
    Tokushige, Katsutoshi
    Hashimoto, Etsuko
    Shiratori, Keiko
    HEPATOLOGY RESEARCH, 2008, 38 (06) : 572 - 579
  • [39] Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
    Komatsu, Michiharu
    Tanaka, Naoki
    Kimura, Takefumi
    Fujimori, Naoyuki
    Sano, Kenji
    Horiuchi, Akira
    Sugiura, Ayumi
    Yamazaki, Tomoo
    Shibata, Soichiro
    Joshita, Satoru
    Umemura, Takeji
    Matsumoto, Akihiro
    Tanaka, Eiji
    HEPATOLOGY RESEARCH, 2018, 48 (13) : 1092 - 1098
  • [40] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127